Building End-of-Life Science through Positive Human Strengths and Traits
通过积极的人类优势和特质建立临终科学
基本信息
- 批准号:7943968
- 负责人:
- 金额:$ 57.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This application proposes establishment of an interdisciplinary biomedical core focused on quality of life research for seriously ill people, including those who are at the end of life. The proposed biomedical core center, Building End-of-Life Science through Positive Human Strengths and Traits (BEST), is supported by a strong interdisciplinary group of researchers, clinicians, and academic leaders In quality of life of patients with advanced Illness and their families. The BEST Center will move the science of palliative care research into a new direction- a paradigm shift that will address the need for investigations of the positive psychological traits that have the greatest influence on an individual's capacity to tolerate and even grow despite the physical and emotional threat of serious illness. The aims of the BEST Center are : (1) establish a Biomedical Core Center (BEST), focused on the following specific targeted area of research: strategies assessing and building on human strengths (such as learned optimism, self-efficacy, social connectedness) in coping with and managing serious illness; (2) formalize and coordinate current informal collaborative relationships among faculty and Institutions in order to support research projects in the targeted area of research; and (3) recruit and support new faculty committed to investigations in the targeted area. In order to do this, the BEST Center will be organized into three cores: (a) the Executive Core; (b) the Outreach and Education Core; and (c) the Mentorship Core. This Center will augment and enhance the capacity of the School of Nursing to investigate the application of findings from positive psychology in the population of patients with serious and life-limiting illness focusing on improving the quality of life in all domains. In addition to creating an organizational structure to support this Initiative, we will recruit and hire three new faculty committed to developing programs of research targeting positive attributes and /or biologic correlates in this population. The BEST Center Is founded on the related research conducted by an interdisciplinary group of faculty from disciplines currently linked in an internal faculty collaborative. Building on this strong base, we will continue to foster strategic collaborations with community programs, clinical practice settings, and existing relationships across institutional levels to promote collaboration and to share research expertise and knowledge related to end-of-life science. A thorough evaluation of the activities and milestones will assist us to measure our success and promote the sustainability of the BEST Center.
描述(由申请人提供):本申请提议建立一个跨学科生物医学核心,重点是针对严重病人的生活质量研究,包括那些处于生命末尾的人。拟议的生物医学核心中心,通过积极的人类优势和特征(最佳)建立寿命科学,得到了一个强大的跨学科研究人员,临床医生和学术领导者的支持,这些研究员,临床医生和学术领袖在患有晚期疾病的患者及其家人及其家人的生活质量方面得到了支持。最好的中心将把姑息治疗研究的科学转移到一个新的方向上 - 范式转变将解决对积极心理特征的调查的需求,这些心理特征对个人的能力具有最大的影响,尽管对个人的耐受能力,尽管对严重疾病造成了身体和情感上的威胁。最佳中心的目的是:(1)建立一个生物医学核心中心(最佳),重点介绍以下特定目标研究领域:在应对和管理严重疾病的应对和管理中,评估和建立人类优势(例如学习的乐观,自我效能,社会联系)的策略; (2)正式和协调教师和机构之间的当前非正式合作关系,以支持目标研究领域的研究项目; (3)招募和支持新教师致力于在目标地区进行调查。为了做到这一点,最好的中心将分为三个核心:(a)行政核心; (b)外展和教育核心; (c)指导核心。该中心将增加和增强护理学院调查积极心理学的发现在严重且限制生命的疾病患者中的发现,重点是改善所有领域的生活质量。除了建立一个组织结构来支持这项倡议外,我们还将招募并聘请三个致力于制定针对积极属性和 /或生物学关系的研究计划的新教师。最好的中心是建立在目前由内部教师合作中联系的学科的跨学科教师小组进行的相关研究。在这个强大的基础的基础上,我们将继续与社区计划,临床实践环境以及跨机构层面的现有关系促进战略合作,以促进协作并分享与终止科学相关的研究专业知识和知识。对活动和里程碑的彻底评估将有助于我们衡量我们的成功并促进最佳中心的可持续性。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex.
家庭凝聚力和沟通对健康相关生活质量的二元影响:性的调节作用。
- DOI:10.1097/ncc.0000000000000468
- 发表时间:2018
- 期刊:
- 影响因子:2.6
- 作者:Lim,Jung-Won;Shon,En-Jung
- 通讯作者:Shon,En-Jung
Confronting Mortality: Narratives of Military Veterans Enrolled in Home Hospice Care.
面对死亡:参加家庭临终关怀的退伍军人的叙述。
- DOI:10.1097/njh.0000000000000250
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Prince-Paul,Maryjo;Peereboom,Karen;Daly,BarbaraJ
- 通讯作者:Daly,BarbaraJ
How Have Long-Term Survivors Coped With Living With HIV?
- DOI:10.1016/j.jana.2012.09.004
- 发表时间:2013-09-01
- 期刊:
- 影响因子:2
- 作者:Slomka, Jacquelyn;Lim, Jung-won;Daly, Barbara
- 通讯作者:Daly, Barbara
共 3 条
- 1
Barbara Daly的其他基金
Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
肿瘤科护士影响:改善与患者有关临床试验的沟通
- 批准号:86669008666900
- 财政年份:2014
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
肿瘤科护士影响:改善与患者有关临床试验的沟通
- 批准号:88655798865579
- 财政年份:2014
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
- 批准号:84727238472723
- 财政年份:2013
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
- 批准号:86649398664939
- 财政年份:2013
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
- 批准号:88754928875492
- 财政年份:2013
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Symptom Management and Palliative Care Research in Adults with Advanced Disease
成人晚期疾病的症状管理和姑息治疗研究
- 批准号:90984679098467
- 财政年份:2013
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Mapping the Complexity of End of Life Transitions in Chronically Critically Ill
绘制慢性危重病患者临终过渡的复杂性
- 批准号:82552238255223
- 财政年份:2011
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Mapping the Complexity of End of Life Transitions in Chronically Critically Ill
绘制慢性危重病患者临终过渡的复杂性
- 批准号:83398928339892
- 财政年份:2011
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Building End-of-Life Science through Positive Human Strengths and Traits
通过积极的人类优势和特质建立临终科学
- 批准号:78502287850228
- 财政年份:2009
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Improving The Quality Of Advanced Cancer Care With Disease Management
通过疾病管理提高晚期癌症护理的质量
- 批准号:74928797492879
- 财政年份:2007
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
相似国自然基金
基于rAAV的基因替代疗法治疗CARD9缺陷相关的侵袭性皮肤癣菌感染研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
基于rAAV的基因替代疗法治疗CARD9缺陷相关的侵袭性皮肤癣菌感染研究
- 批准号:82173428
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
经玻璃体腔基因替代疗法联合抗凋亡基因疗法治疗LCA2及抗凋亡分子机制探索
- 批准号:81970840
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
铁影响雌激素替代疗法在绝经早晚期对动脉粥样硬化疗效的差异
- 批准号:81870348
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
冠心病患者PCI术后西洛他唑替代疗法的可行性及药理机制研究
- 批准号:81803630
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Islet dosing and loading density in injection molded macroencapsulation devices
注塑宏观封装装置中的胰岛剂量和装载密度
- 批准号:1071617410716174
- 财政年份:2023
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Spatial Frequency Dependent Deficits in Anisometropic Amblyopia
屈光参差性弱视的空间频率依赖性缺陷
- 批准号:1070416610704166
- 财政年份:2022
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Spatial Frequency Dependent Deficits in Anisometropic Amblyopia
屈光参差性弱视的空间频率依赖性缺陷
- 批准号:1050719810507198
- 财政年份:2022
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy
识别和量化老年糖尿病患者药物相互作用影响的新方法,重点关注多发病和多药治疗
- 批准号:1059995310599953
- 财政年份:2021
- 资助金额:$ 57.41万$ 57.41万
- 项目类别:
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy
识别和量化老年糖尿病患者药物相互作用影响的新方法,重点关注多发病和多药治疗
- 批准号:1021496610214966
- 财政年份:2021
- 资助金额:$ 57.41万$ 57.41万
- 项目类别: